CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (1y) (2017 - 2026)
CRISPR Therapeutics AG (CRSP) EBITDA Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
656,150.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
656,150.00 |
| Dec 31, 2025 |
-1.50 Mn |
| Sep 30, 2025 |
17,604.00 |
| Jun 30, 2025 |
131,649.00 |
| Mar 31, 2025 |
836,387.00 |
| Dec 31, 2024 |
-17,772.00 |
| Jun 30, 2024 |
-2.46 Mn |
| Mar 31, 2024 |
-2.38 Mn |
| Dec 31, 2023 |
173.27 Mn |
| Jun 30, 2023 |
11.97 Mn |
| Mar 31, 2023 |
2.03 Mn |
| Dec 31, 2022 |
-173.15 Mn |
| Sep 30, 2022 |
-17.23 Mn |
| Jun 30, 2022 |
-11.99 Mn |
| Mar 31, 2022 |
74,140.00 |
| Dec 31, 2021 |
2.78 Mn |
| Sep 30, 2021 |
4.71 Mn |
| Jun 30, 2021 |
18.11 Mn |
| Mar 31, 2021 |
2.34 Mn |
| Dec 31, 2020 |
-2.90 Mn |
